@prefix this: . @prefix sub: . @prefix beldoc: . @prefix rdfs: . @prefix rdf: . @prefix xsd: . @prefix dct: . @prefix dce: . @prefix pav: . @prefix np: . @prefix belv: . @prefix prov: . @prefix go: . @prefix Protein: . @prefix hgnc: . @prefix geneProductOf: . @prefix hasAgent: . @prefix obo: . @prefix occursIn: . @prefix species: . @prefix pubmed: . @prefix orcid: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { sub:_1 hasAgent: sub:_2; a go:0042789 . sub:_2 geneProductOf: hgnc:9955; a Protein: . sub:_3 hasAgent: sub:_4; a go:0042789 . sub:_4 geneProductOf: hgnc:9232; a Protein: . sub:_5 occursIn: obo:CLO_0001601, obo:CL_0000192, obo:UBERON_0000947, species:9606; rdf:object sub:_3; rdf:predicate belv:decreases; rdf:subject sub:_1; a rdf:Statement . sub:assertion rdfs:label "tscript(p(HGNC:RELA)) -| tscript(p(HGNC:PPARA))" . } sub:provenance { beldoc: dce:description "Approximately 61,000 statements."; dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved."; dce:title "BEL Framework Large Corpus Document"; pav:authoredBy sub:_7; pav:version "20131211" . sub:_6 prov:value "activation of PPARa represses p65 transactivation of the human IL-6 promoter. This antagonism occurs in a reciprocal manner, since cotransfection of increasing amounts of p65 led to a dosedependent inhibition of a PPARa-mediated activation of a PPAR response element-driven promoter. Transrepression occurs through direct protein-protein interactions between PPARa and the p65 subunit of NF-kB [28]."; prov:wasQuotedFrom pubmed:14561188 . sub:_7 rdfs:label "Selventa" . sub:assertion prov:hadPrimarySource pubmed:14561188; prov:wasDerivedFrom beldoc:, sub:_6 . } sub:pubinfo { this: dct:created "2014-07-03T14:32:10.117+02:00"^^xsd:dateTime; pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 . }